You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2025

Drug Price Trends for NDC 71767-0100


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 71767-0100

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
FUROSCIX 80MG/10ML, KIT SC Pharmaceuticals Inc. 71767-0100-01 1 602.86 602.86000 2024-01-01 - 2028-11-14 FSS
FUROSCIX 80MG/10ML, KIT SC Pharmaceuticals Inc. 71767-0100-01 1 603.09 603.09000 2023-11-15 - 2028-11-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

71767-0100 Market Analysis and Financial Projection

Market Analysis and Price Projections for Furosemide (NDC: 71767-0100-01)

Introduction

Furosemide, a diuretic medication, is widely used for treating fluid overload in patients with chronic heart failure. The specific product in focus here is Furoscix, a subcutaneous furosemide injection with the NDC code 71767-0100-01, manufactured by SC Pharmaceuticals Inc.

Current Market Pricing

As of the latest data, the wholesale price for Furoscix 80mg/10ml kit is around $603.09 per unit, with slight variations depending on the pricing period and source[1].

Market Trends and Drivers

The pharmaceutical market, including drugs like furosemide, is influenced by several key trends:

Digital Transformation and Innovation

The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. Technologies like AI and genomics are expected to boost operational efficiencies and drive breakthrough innovations, which could impact pricing and market dynamics[3].

Generic and Biosimilar Competition

Generic drugs and biosimilars are increasingly competitive in the market. For furosemide, the presence of generic versions can affect pricing. The median price increase for generic drugs was 19.9% in 2022, indicating a volatile pricing environment[2].

Regulatory and Transparency Issues

Regulatory transparency is a critical issue in the pharmaceutical industry. Programs like the Prescription Drug Price Transparency Program in Oregon highlight the need for better transparency across the supply chain to understand what influences drug prices. This includes aspects like coupons, discounts, fees, and rebates[2].

Price Projections

Given the current market trends, here are some key points to consider for price projections:

Generic Drug Price Increases

Historical data shows significant price increases for generic drugs. For example, a generic naproxen saw a 2,527% price increase between 2012 and 2021. While such extreme increases are rare, they indicate the potential volatility in generic drug pricing[2].

Market Growth and Demand

The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, driven by factors like increasing R&D investments and the rising adoption of AI-based tools for drug discovery. This growth could influence the pricing of essential medications like furosemide[4].

Patent Cliff and Mergers and Acquisitions

The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, which could lead to increased competition from generics and biosimilars. This trend might drive mergers and acquisitions, potentially affecting the pricing strategies of companies involved[3].

Specific Projections for Furoscix

Given the current wholesale price of around $603.09 per unit, several factors could influence future pricing:

  • Regulatory Changes: If states or federal authorities implement upper payment limits or other price control measures, it could cap the price of Furoscix and other high-cost drugs[2].
  • Market Competition: Increased competition from generic furosemide products could drive prices down. However, the unique delivery mechanism of Furoscix (subcutaneous injection) might maintain a premium pricing due to its convenience and efficacy[5].
  • Economic Factors: The overall growth of the pharmaceutical market and increasing healthcare costs could lead to higher prices if not regulated. However, the use of AI and other innovations might help in reducing production costs, potentially stabilizing or reducing prices[3][4].

Conclusion

The pricing of Furoscix, like other pharmaceuticals, is influenced by a complex interplay of regulatory, market, and technological factors. While current prices are around $603.09 per unit, future prices could be affected by increased transparency, regulatory measures, and market competition.

Key Takeaways

  • Current Pricing: Furoscix is priced around $603.09 per unit.
  • Market Trends: Digital transformation, generic competition, and regulatory transparency are key drivers.
  • Price Volatility: Generic drug prices can be highly volatile.
  • Regulatory Impact: Upper payment limits and transparency measures could cap prices.
  • Market Growth: The US pharmaceutical market is projected to grow significantly by 2030.

FAQs

Q: What is the current wholesale price of Furoscix? A: The current wholesale price of Furoscix 80mg/10ml kit is around $603.09 per unit[1].

Q: What are the main drivers of the pharmaceutical market? A: The main drivers include digital transformation, generic and biosimilar competition, and regulatory transparency[2][3].

Q: How might regulatory changes affect the price of Furoscix? A: Regulatory changes such as upper payment limits could cap the price of Furoscix and other high-cost drugs[2].

Q: What is the projected growth of the US pharmaceutical market? A: The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030[4].

Q: How does the unique delivery mechanism of Furoscix impact its pricing? A: The subcutaneous injection mechanism of Furoscix might maintain a premium pricing due to its convenience and efficacy compared to traditional oral or intravenous furosemide[5].

Sources

  1. DrugPatentWatch - Pharmaceutical drug prices and trends for FUROSEMIDE.
  2. Oregon Department of Consumer and Business Services - Prescription Drug Price Transparency Results and Recommendations.
  3. Deloitte Insights - 2025 life sciences outlook.
  4. GlobeNewswire - US Pharmaceutical Market Review 2020-2023 and Forecast.
  5. DailyMed - FUROSCIX- furosemide injection 80 mg/ 10 ml injection.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.